These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 16231594

  • 1. The treatment of NAFLD.
    Trappoliere M, Tuccillo C, Federico A, Di Leva A, Niosi M, D'Alessio C, Capasso R, Coppola F, Dauria M, Loguercio C.
    Eur Rev Med Pharmacol Sci; 2005; 9(5):299-304. PubMed ID: 16231594
    [Abstract] [Full Text] [Related]

  • 2. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 3. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH.
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [Abstract] [Full Text] [Related]

  • 4. Diabetes mellitus, obesity, and hepatic steatosis.
    Youssef W, McCullough AJ.
    Semin Gastrointest Dis; 2002 Jan; 13(1):17-30. PubMed ID: 11944630
    [Abstract] [Full Text] [Related]

  • 5. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 6. Nonalcoholic fatty liver disease.
    Yu AS, Keeffe EB.
    Rev Gastroenterol Disord; 2002 Jul; 2(1):11-9. PubMed ID: 12122975
    [Abstract] [Full Text] [Related]

  • 7. Current treatment of non-alcoholic fatty liver disease.
    Ahmed MH, Byrne CD.
    Diabetes Obes Metab; 2009 Mar; 11(3):188-95. PubMed ID: 18564173
    [Abstract] [Full Text] [Related]

  • 8. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
    Grønbaek H, Eivindson MV, Hamilton-Dutoit S, Vilstrup H.
    Ugeskr Laeger; 2003 Mar 10; 165(11):1115-8. PubMed ID: 12677985
    [Abstract] [Full Text] [Related]

  • 9. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S, Younossi ZM.
    Minerva Gastroenterol Dietol; 2006 Jun 10; 52(2):135-43. PubMed ID: 16557185
    [Abstract] [Full Text] [Related]

  • 10. Nonalcoholic fatty liver disease.
    Hjelkrem MC, Torres DM, Harrison SA.
    Minerva Med; 2008 Dec 10; 99(6):583-93. PubMed ID: 19034256
    [Abstract] [Full Text] [Related]

  • 11. The metabolic syndrome and nonalcoholic fatty liver disease.
    Collantes RS, Ong JP, Younossi ZM.
    Panminerva Med; 2006 Mar 10; 48(1):41-8. PubMed ID: 16633331
    [Abstract] [Full Text] [Related]

  • 12. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H, Daram SR.
    Postgrad Med; 2008 Jul 31; 120(2):E01-7. PubMed ID: 18654060
    [Abstract] [Full Text] [Related]

  • 13. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
    Carter-Kent C, Zein NN, Feldstein AE.
    Am J Gastroenterol; 2008 Apr 31; 103(4):1036-42. PubMed ID: 18177455
    [Abstract] [Full Text] [Related]

  • 14. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
    Ali R, Cusi K.
    Ann Med; 2009 Apr 31; 41(4):265-78. PubMed ID: 19353360
    [Abstract] [Full Text] [Related]

  • 15. Therapy of nonalcoholic fatty liver disease: current status.
    Duvnjak M, Tomasic V, Gomercic M, Smircic Duvnjak L, Barsic N, Lerotic I.
    J Physiol Pharmacol; 2009 Dec 31; 60 Suppl 7():57-66. PubMed ID: 20388946
    [Abstract] [Full Text] [Related]

  • 16. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S.
    Gastroenterology; 2007 Jan 31; 132(1):282-93. PubMed ID: 17241878
    [Abstract] [Full Text] [Related]

  • 17. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.
    Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, Doo E, Ghany M, Premkumar A, Park Y, Liang TJ, Yanovski JA, Kleiner DE, Hoofnagle JH.
    Hepatology; 2004 Jan 31; 39(1):188-96. PubMed ID: 14752837
    [Abstract] [Full Text] [Related]

  • 18. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.
    Cave M, Deaciuc I, Mendez C, Song Z, Joshi-Barve S, Barve S, McClain C.
    J Nutr Biochem; 2007 Mar 31; 18(3):184-95. PubMed ID: 17296492
    [Abstract] [Full Text] [Related]

  • 19. Nonalcoholic fatty liver disease as a complication of insulin resistance.
    Abdelmalek MF, Diehl AM.
    Med Clin North Am; 2007 Nov 31; 91(6):1125-49, ix. PubMed ID: 17964913
    [Abstract] [Full Text] [Related]

  • 20. Effects of weight loss on nonalcoholic fatty liver disease.
    Rafiq N, Younossi ZM.
    Semin Liver Dis; 2008 Nov 31; 28(4):427-33. PubMed ID: 18956298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.